A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma

NCT00980382 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

85

Enrollment

OTHER_GOV

Sponsor class

Conditions

Stomach Neoplasms

Interventions

DRUG: S-1, Docetaxel

Sponsor

National Cancer Center, Korea